(Q28248288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

AVP

0 references

stress-related disorders

1 reference

inferred from title

author name string

Claudine Serradeil-Le Gal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Jean Wagnon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Bernard Tonnerre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Richard Roux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Georges Garcia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Guy Griebel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Alain Aulombard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

53-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

Pancreatic vasopressin V1breceptors: characterization in In-R1-G9 cells and localization in human pancreas

11 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2005.TB00035.X

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2005.TB00035.X

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation

21 January 2018

1 reference

12 December 2020

Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin

1 reference

12 December 2020

Regulation of adult neurogenesis by psychotropic drugs and stress.

1 reference

12 December 2020

1 reference

12 December 2020

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

12 December 2020

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

1 reference

12 December 2020

Anxious-retarded depression: relation with plasma vasopressin and cortisol

1 reference

12 December 2020

Neuropeptides involved in the pathophysiology of schizophrenia and major depression

1 reference

12 December 2020

Chronic corticotropin-releasing hormone and vasopressin regulate corticosteroid receptors in rat hippocampus and anterior pituitary

1 reference

12 December 2020

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

1 reference

12 December 2020

The role of peptides in treatment of psychiatric disorders.

1 reference

12 December 2020

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

1 reference

12 December 2020

Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

1 reference

12 December 2020

Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor

1 reference

12 December 2020

Preservation of a conditioned avoidance response by lysine vasopressin.

1 reference

12 December 2020

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

1 reference

12 December 2020

The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum.

1 reference

12 December 2020

Behavioral effects of neuropeptides: endorphins and vasopressin

1 reference

12 December 2020

Extrapituitary expression of the rat V1b vasopressin receptor gene

1 reference

12 December 2020

Cloning and characterization of the human V3 pituitary vasopressin receptor

1 reference

12 December 2020

Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor

1 reference

12 December 2020

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors

1 reference

12 December 2020

Antidepressants and hypothalamic-pituitary-adrenocortical regulation

1 reference

12 December 2020

Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease

1 reference

12 December 2020

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

1 reference

12 December 2020

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways

1 reference

12 December 2020

Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide

1 reference

12 December 2020

Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain.

1 reference

12 December 2020

Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.

1 reference

12 December 2020

10.1111/J.1527-3458.2005.TB00035.X

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

4942699

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4942699

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867952%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2 references

Consolidated OpenCitations Corpus – April 2017

4942699